Research Analysts Set Expectations for JSPR Q1 Earnings
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued to investors on Thursday, February 27th. William Blair analyst M. Phipps forecasts that the company will post earnings per share of ($1.14) for the quarter. The […]
